Vivek Ramaswamy
CIK 1635075 · Principal Executive Officer · last filed 2025-12-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ROIV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
853 NEW JERSEY AVE., SE STE. 200-231
WASHINGTON, DC 20003
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | 10%+ Owner | 47,011,612 | $39.24 | $1.84B | -$193.16M | 10 | 2025-12-15 |
| ASST | 10%+ Owner | 1,419,722 | $16.75 | $23.79M | $1.25M | 2 | 2025-11-07 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 54,730,523 | $2.75 | $150.51M | -$31.80M | 4 | 2023-08-29 |
| ABUS | Director | — | $4.12 | — | $0 | 4 | 2018-06-22 |
Holdings By Holder
Recent Filings · Page 3 of 4
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-29 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | +39,022 | -$536.5K | EDGAR |
| 2023-08-28 | ROIV | Notice (144) 10% Owner · Planned Aug 28, 2023 · 10b5-1 plan Sold: listed on the Sep 28, 2023 notice |
−86,714 | -$966.0K | EDGAR |
| 2023-08-01 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | +90,034 | -$868.9K | EDGAR |
| 2023-07-28 | ROIV | Notice (144) 10% Owner · Planned Jul 28, 2023 · 10b5-1 plan Sold: listed on the Aug 28, 2023 notice |
−166,057 | -$1.79M | EDGAR |
| 2023-05-31 | ROIV | Notice (144/A) 10% Owner · Planned May 30, 2023 · 10b5-1 plan Sold: listed on the Jul 28, 2023 notice |
−382,203 | -$3.56M | EDGAR |
| 2023-05-31 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | +192,256 | -$1.73M | EDGAR |
| 2023-02-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −4,000,000 | -$31.80M | EDGAR |
| 2018-06-22 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2017-06-23 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2016-06-07 | ABUS | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
3 sales · $3.13M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2023-08-28 | ROIV | 47,692 | $536.5K | $11.25 | 2023-09-28 |
| 2023-07-31 | ROIV | 76,023 | $868.9K | $11.43 | 2023-08-28 |
| 2023-05-31 | ROIV | 189,947 | $1.73M | $9.09 | 2023-07-28 |